Department of Life and Health Sciences, University of Nicosia, Cyprus.
Department of Life and Health Sciences, University of Nicosia, Cyprus; Diabetes and Nutritional Sciences Division, King's College London, London, UK.
Autoimmun Rev. 2018 Nov;17(11):1105-1114. doi: 10.1016/j.autrev.2018.06.007. Epub 2018 Sep 10.
The impact of dietary interventions such as specific types of diet or nutritional supplements in rheumatoid arthritis (RA) has been subject to increased attention in recent years. The recognition of the unmet need to better understand the effects of specific dietary interventions on disease outcomes in RA, along with the growing patient interest on lifestyle interventions beyond pharmacotherapy, have informed the undertaking of this narrative literature review. The benefits of the Mediterranean Diet (MD) have been shown in various studies, although only a limited number of trials focus specifically on RA. Based on the studies reviewed, the MD may provide benefits in reducing pain and swollen and tender joints in RA patients. There is more and better evidence that n-3 polyunsaturated fat (PUFA) supplementation has the potential to reduce inflammation and provide clinical benefit, possibly slowing progression to pharmacotherapy. Yet, many of these studies to date are limited in their methodology; this being partly a reflection of the complexity of the research questions being addressed. Consequently, the conclusions that can be robustly drawn from their results are restricted. With a focus on clinical trials on the MD and fish oil supplementation, this review critically appraises the evidence, discussing the findings of studies in the wider context of impact on RA outcomes, methodological challenges, and practical points to consider as part of the routine care of RA patients.
近年来,饮食干预(如特定类型的饮食或营养补充剂)对类风湿关节炎(RA)的影响受到了越来越多的关注。人们认识到,需要更好地了解特定饮食干预对 RA 疾病结局的影响,再加上患者对药物治疗以外的生活方式干预的兴趣日益增加,这促使人们进行了这篇叙述性文献综述。地中海饮食(MD)的益处已在多项研究中得到证实,尽管只有少数试验专门针对 RA。根据综述的研究,MD 可能有助于减轻 RA 患者的疼痛和肿胀关节。越来越多的证据表明,n-3 多不饱和脂肪酸(PUFA)补充剂具有减轻炎症和提供临床益处的潜力,可能减缓向药物治疗的进展。然而,迄今为止,许多此类研究在方法学上存在局限性;这在一定程度上反映了所解决的研究问题的复杂性。因此,从这些结果中可以得出的结论受到限制。本文重点关注 MD 和鱼油补充剂的临床试验,批判性地评估了证据,讨论了在更广泛的 RA 结局影响背景下、在方法学挑战方面以及在 RA 患者常规护理中需要考虑的实际问题方面的研究发现。